TOTAL PRODUCTION - Centre de Recherche des Cordeliers
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Research unit evaluation
November 2016
TOTAL PRODUCTION
Nom de l’équipe : Control of Metabolic Inflammation in T2D and its Complications
Nom du directeur pour le contrat en cours : Ronan ROUSSEL (CRC Team) and Nicolas VENTECLEF (ERC Team)
Nom du directeur pour le contrat à venir : Nicolas VENTECLEF
I. PRODUITS DE LA RECHERCHE
Publications done in collaboration with another team of the CRC are flagged with ■
1. Journaux / revues
Articles scientifiques
2017
1. ■ Anaïs Szpigel, Isabelle Hainault, Aurélie Carlier, Nicolas Venteclef, Anne-Françoise
Batto, Eric Hajduch, Catherine Bernard, Alain Ktorza, Jean-François Gautier, Pascal
Ferré, Olivier Bourron, Fabienne Foufelle . Lipid environment induces an endoplasmic
reticulum stress, TXNIP expression and inflammation in immune cells of type 2 diabetic
patients. Diabetologia 2017 accepted (IF : 6)
2. Roussel R, Velho G, Bankir L. Vasopressin and diabetic nephropathy. Curr Opin Nephrol
Hypertens. 2017 Jul;26(4):311-318. Potier L, Roussel R, Elbez Y, Marre M, Zeymer U, Reid CM,
Ohman M, Eagle KA, Bhatt DL, Steg PG; REACH Registry Investigators*. Angiotensin-converting
enzyme inhibitors and angiotensin receptor blockers in high vascular risk. Heart. 2017
Sep;103(17):1339-1346. (IF: 6.1)
3. Balkau B, Roussel R, Wagner S, Tichet J, Froguel P, Fagherazzi G, Bonnet F; D.E.S.I.R. Study
Group. Transmission of Type 2 diabetes to sons and daughters: the D.E.S.I.R. cohort. Diabet
Med. 2017 Aug 9.
4. Roussel R, d'Emden MC, Fisher M, Ampudia-Blasco FJ, Stella P, Bizet F, Cali AMG, Wysham CH.
Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice-daily
basal insulin to once-daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and
EDITION 2 subgroup analysis). Diabetes Obes Metab. 2017 Jul 24. (IF: 6.7)
5. Roussel R, Steg PG, Mohammedi K, Marre M, Potier L. Prevention of cardiovascular disease
through reduction of glycaemic exposure in type 2 diabetes: A perspective on glucose-lowering
interventions. Diabetes Obes Metab. 2017 Jun 9. doi: 10.1111/dom.13033. [Epub ahead of
print]. (IF: 6.7)
6. Benkhadra K, Alahdab F, Tamhane S, Wang Z, Prokop LJ, Hirsch IB, Raccah D, Riveline JP,
Kordonouri O, Murad MH (2017). Real-time continuous glucose monitoring in type 1 diabetes: a
systematic review and individual patient data meta-analysis. Clin Endocrinol (Oxf).
Mar;86(3):354-360. doi: 10.1111/cen.13290.
7. ■ Besseiche A, Riveline JP, Delavallée L, Foufelle F, Gautier JF, Blondeau B (2017). Oxidative and
energetic stresses mediate beta-cell dysfunction induced by PGC-1α. Diabetes Metab. doi:
10.1016/j.diabet.2017.01.007.
8. Bonnefond, A., L. Yengo, A. Dechaume, M. Canouil, M. Castelain, E. Roger, F. Allegaert, R.
Caiazzo, V. Raverdy, M. Pigeyre, A. Arredouani, J. M. Borys, C. Levy-Marchal, J. Weill, R. Roussel,
B. Balkau, M. Marre, F. Pattou, T. Brousseau and P. Froguel (2017). "Relationship between
salivary/pancreatic amylase and body mass index: a systems biology approach." BMC Med
15(1): 37.
1
Group D: evaluation campaign 2017 - 2018
Department for the evaluation of research unitsResearch unit evaluation
November 2016
9. Bonnet, F., A. Gastaldelli, F. Pihan-Le Bars, A. Natali, R. Roussel, J. Petrie, J. Tichet, M. Marre, B.
Fromenty, B. Balkau and R. S. G. D.E.S.I.R (2017). "Gamma-glutamyltransferase, fatty liver index
and hepatic insulin resistance are associated with incident hypertension in two longitudinal
studies." J Hypertens 35(3): 493-500.
10. Brahimi N, Potier L, Mohammedi K (2017). Cutaneous adverse events related to FreeStyle Libre
device. Lancet. Apr 8;389(10077):1396
11. Choukem, S. P., J. Kamdeu-Chedeu, S. D. Leary, Y. Mboue-Djieka, D. N. Nebongo, C. Akazong, Y.
N. Mapoure, J. P. Hamilton-Shield, J. F. Gautier and J. C. Mbanya (2017). "Overweight and
obesity in children aged 3-13 years in urban Cameroon: a cross-sectional study of prevalence
and association with socio-economic status." BMC Obes 4: 7.
12. Desilles JP, Syvannarath V, Ollivier V, Journé C, Delbosc S, Ducroux C, Boisseau W, Louedec L, Di
Meglio L, Loyau S, Jandrot-Perrus M, Potier L, Michel JB, Mazighi M, Ho-Tin-Noé B (2017).
Exacerbation of Thromboinflammation by Hyperglycemia Precipitates Cerebral Infarct Growth
and Hemorrhagic Transformation. Stroke. Doi: 10.1161/STROKEAHA.117.017080.
13. Desposito D, Zadigue G, Taveau C, Adam D, Alhenc-Gelas F, Bouby N, Roussel R. Neuroprotective
effect of kinin B1 receptor activation on acute cerebral ischemia in diabetic mice. Sc Reports
2017
14. Ding M, Huang T, Bergholdt HKM, Frazier-Wood AC, Aslibekyan S, North KE, Voortman T, Graff
M, Smith CE, Lai CQ, Varbo A, Lemaitre RN, de Jonge EAL, Fumeron F, Corella D, Wang CA,
Tjønneland A, Overvad K, Sørensen TIA, Feitosa MF, Wojczynski MK, Kähönen M, Ahmad S,
Renström F, Psaty BM, Siscovick DS, Barroso I, Johansson I, Hernandez D, Ferrucci L, Bandinelli S,
Linneberg A, Sandholt CH, Pedersen O, Torben Hansen T, Schulz CA, Sonestedt E, Orho-
Melander M, Chen TA, Rotter JI, Allison MA, Rich SA, Sorlí JV, Coltell O, Pennell CE, Eastwood P,
Hofman A, Uitterlinden AG, Zillikens MC, van Rooij FJA, Chu AY, Rose LM, Ridker PM, Viikari J,
Raitakari O, Lehtimäki T, Mikkilä V, Willett WC, Yujie Wang, Tucker KL, Ordovas JM, Kilpeläinen
TO, Province MA, Franks PW, Arnett DK, Tanaka T, Toft U, Ericson U, Franco OH, CHARGE
consortium, Mozaffarian D, Hu FB, Chasman DI, Nordestgaard BG, Ellervik C, Qi L (2017). Dairy
Consumption, Systolic Blood Pressure and Risk of Hypertension: Mendelian Randomization
Study. Br Med J Mar 16;356:j1000
15. Dos Santos, R. S., M. Daures, A. Philippi, S. Romero, L. Marselli, P. Marchetti, V. Senee, D. Bacq,
C. Besse, B. Baz, L. Marroqui, S. Ivanoff, J. Masliah-Planchon, M. Nicolino, J. Soulier, G. Socie, D.
L. Eizirik, J. F. Gautier and C. Julier (2017). "dUTPase (DUT) Is Mutated in a Novel Monogenic
Syndrome With Diabetes and Bone Marrow Failure." Diabetes 66(4): 1086-1096. (IF: 8.9)
16. El Boustany R, Taveau, C Chollet, Velho G, Bankir L, Alhenc-Gelas F, Roussel R, Bouby N (2017).
Antagonism of vasopressin V2 receptor improves albuminuria at the early stage of diabetic
nephropathy in a mouse model of type 2 diabetes. J Diabetes Complic doi:
10.1016/j.jdiacomp.2017.04.005 (IF: 4.9)
17. Feigerlova, E., P. J. Saulnier, P. Gourdy, R. Roussel, J. M. Halimi, E. Gand, D. Dardari, B. Guerci, P.
Sosner, M. Marre, P. Zaoui, S. Ragot, S. Hadjadj and S. S. G. Diab 2 Nephrogene (2017). "Sex
hormone levels are not associated with progression of renal disease in male patients with
T2DM." Diabetes Metab 43(2): 140-145.
18. Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G (2017). Use of Flash Glucose-
Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-
treated Type 2 Diabetes. Diabetes Ther. 8(3):573-586. doi: 10.1007/s13300-017-0255-6.
19. Hussein, H., F. Ibrahim, E. Sobngwi, J. F. Gautier and P. Boudou (2017). "Zinc transporter 8
autoantibodies assessment in daily practice." Clin Biochem 50(1-2): 94-96.
20. Lontchi-Yimagou, E., J. L. Nguewa, F. Assah, J. J. Noubiap, P. Boudou, E. Djahmeni, E. V. Balti, B.
Atogho-Tiedeu, J. F. Gautier, J. C. Mbanya and E. Sobngwi (2017). "Ketosis-prone atypical
diabetes in Cameroonian people with hyperglycaemic crisis: frequency, clinical and metabolic
phenotypes." Diabet Med 34(3): 426-431.
21. Martinez, L., A. Penfornis, J. F. Gautier, E. Eschwege, G. Charpentier, A. Bouzidi and P. Gourdy
(2017). "Effectiveness and Persistence of Liraglutide Treatment Among Patients with Type 2
2
Group D: evaluation campaign 2017 - 2018
Department for the evaluation of research unitsResearch unit evaluation
November 2016
Diabetes Treated in Primary Care and Specialist Settings: A Subgroup Analysis from the
EVIDENCE Study, a Prospective, 2-Year Follow-up, Observational, Post-Marketing Study." Adv
Ther 34(3): 674-685.
22. Mohammedi, K., A. Compaore, L. Potier, N. Belhatem, M. Feron, N. Matallah, F. Travert, B.
Hansel, G. Velho, R. Roussel, M. Hallab and M. Marre (2017). "Outpatient measurement of
arterial stiffness in patients with type 2 diabetes and obesity." J Diabetes 9(3): 237-242.
23. Moutairou, A., R. Roussel, B. Charbonnel, A. Leye, B. Detournay, K. Mohammedi and L. Potier
(2017). "Predicting severe hypoglycaemia with self-monitoring of blood glucose in type 1
diabetes." Diabetes Metab.
24. Moutairou, A., R. Roussel, B. Charbonnel, R. El Boustany, A. Nicolas, A. Leye, K. Mohammedi, M.
Marre, B. Detournay and L. Potier (2017). "Short-term effect of severe hypoglycaemia on
glycaemic control in the Diabetes Control and Complications Trial." Diabetes Metab 43(2): 187-
190.
25. ✏ Naufahu J, F Alzaid, M Fiuza Brito, B Doslikova, T Valencia, A Cunliffe and JF Murray (2017).
Melanin-concentrating hormone in peripheral circulation in the human. J Endocrinol 232(3):
513-523.
26. Nguewa, J. L., E. Lontchi-Yimagou, F. Agbelika, M. AitDjoudi, P. Boudou, S. Choukem, E. Sobngwi
and J. F. Gautier (2017). "Relationship between HHV8 infection markers and insulin sensitivity in
ketosis-prone diabetes." Diabetes Metab 43(1): 79-82.
27. Nicolas A, Aubert R, Bellili-Muñoz N, Balkau B, Bonnet F, Tichet J, Velho G, Marre M, Roussel R,
Fumeron F (2017). T-cadherin gene variants are associated with type 2 diabetes and the Fatty
Liver Index in the French population. Diabetes Metab 43: 33–39.
28. Nicolas, A., K. Mohammedi, J. P. Bastard, S. Fellahi, N. Bellili-Munoz, R. Roussel, S. Hadjadj, M.
Marre, G. Velho and F. Fumeron (2017). "T-cadherin gene variants are associated with
nephropathy in subjects with type 1 diabetes." Nephrol Dial Transplant. May 12. doi:
10.1093/ndt/gfx071.
29. Paige, E., J. Barrett, L. Pennells, M. Sweeting, P. Willeit, E. Di Angelantonio, V. Gudnason, B. G.
Nordestgaard, B. M. Psaty, U. Goldbourt, L. G. Best, G. Assmann, J. T. Salonen, P. J. Nietert, W.
M. Verschuren, E. J. Brunner, R. A. Kronmal, V. Salomaa, S. J. Bakker, G. R. Dagenais, S. Sato, J. H.
Jansson, J. Willeit, A. Onat, A. G. de la Camara, R. Roussel, H. Volzke, R. Dankner, R. W. Tipping,
T. W. Meade, C. Donfrancesco, L. H. Kuller, A. Peters, J. Gallacher, D. Kromhout, H. Iso, M.
Knuiman, E. Casiglia, M. Kavousi, L. Palmieri, J. Sundstrom, B. R. Davis, I. Njolstad, D. Couper, J.
Danesh, S. G. Thompson and A. Wood (2017). "Repeated Measurements of Blood Pressure and
Cholesterol Improves Cardiovascular Disease Risk Prediction: An Individual-Participant-Data
Meta-Analysis." Am J Epidemiol. 2017 May 26
30. Potier L, Roussel R, Elbez Y, Marre M, Zeymer U, Reid CM, Ohman M, Eagle KA, Bhatt DL, Steg
PG (2017). REACH Registry Investigators. Angiotensin-converting enzyme inhibitors and
angiotensin receptor blockers in high vascular risk. Heart. Mar 11. pii: heartjnl-2016-310705.
31. Riveline JP, Boudou P, Blondeau B, Gautier JF (2017). Glucagon-secretion inhibition using
somatostatin: An old hormone for the treatment of diabetes-associated pancreatectomy.
Diabetes Metab. 43(3):269-271. doi: 10.1016/j.diabet.2016.08.002.
32. Roussel, R., G. Velho and L. Bankir (2017). "Vasopressin and diabetic nephropathy." Curr Opin
Nephrol Hypertens 26(4): 311-318.
33. Saulnier PJ, Gand E, Ragot S, Bankir L, Piguel X, Fumeron F, Rigalleau V, Halimi JM, Maréchaud R,
Roussel R, Hadjadj S (2017). Urinary sodium concentration is an independent predictor of all-
cause and cardiovascular mortality in a type 2 diabetes cohort population. J Diab Res; 5327352.
doi: 10.1155/2017/5327352
34. Saulnier-Blache, J. S., E. Feigerlova, J. M. Halimi, P. Gourdy, R. Roussel, B. Guerci, A. Dupuy, J.
Bertrand-Michel, J. L. Bascands, S. Hadjadj and J. P. Schanstra (2017). "Urinary lysophopholipids
are increased in diabetic patients with nephropathy." J Diabetes Complications.
35. Saulnier, P. J., E. Gand, G. Velho, K. Mohammedi, P. Zaoui, M. Fraty, J. M. Halimi, R. Roussel, S.
Ragot, S. Hadjadj and S. S. Group (2017). "Association of Circulating Biomarkers
3
Group D: evaluation campaign 2017 - 2018
Department for the evaluation of research unitsResearch unit evaluation
November 2016
(Adrenomedullin, TNFR1, and NT-proBNP) With Renal Function Decline in Patients With Type 2
Diabetes: A French Prospective Cohort." Diabetes Care 40(3): 367-374.
36. Saulnier, P. J., E. Gand, S. Ragot, L. Bankir, X. Piguel, F. Fumeron, V. Rigalleau, J. M. Halimi, R.
Marechaud, R. Roussel, S. Hadjadj and S. Study Group (2017). "Urinary Sodium Concentration Is
an Independent Predictor of All-Cause and Cardiovascular Mortality in a Type 2 Diabetes Cohort
Population." J Diabetes Res 2017: 5327352.
37. Taveau C, Chollet C, Bichet DG, Velho G, Guillon G, Corbani M, Roussel R, Bankir L, Melander O,
Bouby N (2017). Acute and chronic hyperglycemic effects of vasopressin in normal rats,
involvement of V1a receptors. Am J Physiol Endocrinol Metab 2017 Mar 1;312(3):E127-E135
38. Vatier, C., L. Arnaud, X. Prieur, B. Guyomarch, C. Le May, E. Bigot, M. Pichelin, A. Daguenel, M. C.
Vantyghem, J. F. Gautier, C. Vigouroux and B. Cariou (2017). "One-year metreleptin therapy
decreases PCSK9 serum levels in diabetic patients with monogenic lipodystrophy syndromes."
Diabetes Metab 43(3): 275-279.
39. Wigger, L., C. Cruciani-Guglielmacci, A. Nicolas, J. Denom, N. Fernandez, F. Fumeron, P.
Marques-Vidal, A. Ktorza, W. Kramer, A. Schulte, H. Le Stunff, R. Liechti, I. Xenarios, P.
Vollenweider, G. Waeber, I. Uphues, R. Roussel, C. Magnan, M. Ibberson and B. Thorens (2017).
"Plasma Dihydroceramides Are Diabetes Susceptibility Biomarker Candidates in Mice and
Humans." Cell Rep 18(9): 2269-2279. (IF:7.8)
40. Zain M, Awan FR, Najam SS, Islam M, Khan AR, Bilal A, Bellili N, Marre M, Roussel R, Fumeron F
(2017). Association of ACACB gene polymorphism (rs2268388, G>A) with type 2 diabetes and
end stage renal disease in Pakistani Punjabi population. Meta Gene; 12:109–112
2016
41. Ahren, B., G. Galstyan, J. F. Gautier, F. Giorgino, F. Gomez-Peralta, M. Krebs, E. Nikonova, W.
Stager and H. Vargas-Uricoechea (2016). "Postprandial Glucagon Reductions Correlate to
Reductions in Postprandial Glucose and Glycated Hemoglobin with Lixisenatide Treatment in
Type 2 Diabetes Mellitus: A Post Hoc Analysis." Diabetes Ther 7(3): 583-590.
42. Al-Salameh, A., C. Baudry, J. F. Gautier, M. E. Toubert, H. Bihan and R. Cohen (2016). "Late liver
metastasis of medullary thyroid cancer with low calcitonin levels - successfully cured by
radiofrequency." Endokrynol Pol 67(3): 326-329.
43. ■ Alzaid F, F Lagadec, M Albuquerque, R Ballaire, L Orliaguet, I Hainault, C Blugeon, S Lemoine,
A Lehuen, DG Saliba, IA Udalova, V Paradis, F Foufelle and N Venteclef (2016). IRF5 governs liver
macrophage activation that promotes hepatic fibrosis in mice and humans. JCI Insight 1(20):
e88689.
44. Ayina, C. N., J. J. Noubiap, L. S. Etoundi Ngoa, P. Boudou, J. F. Gautier, M. K. Mengnjo, J. C.
Mbanya and E. Sobngwi (2016). "Association of serum leptin and adiponectin with
anthropomorphic indices of obesity, blood lipids and insulin resistance in a Sub-Saharan African
population." Lipids Health Dis 15: 96.
45. Azevedo Da Silva M, Balkau B, Roussel R, Tichet J, Fumeron F, Fagherazzi G, Nabi H; D.E.S.I.R.
study group (2016). Longitudinal association of antidepressant medication use with metabolic
syndrome: Results of a 9-year follow-up of the D.E.S.I.R. cohort study.
Psychoneuroendocrinology; 74:34-45.
46. Balazard, F… J. F. Gautier… M. Raoulx and A. G. Dumont (2016). "Association of environmental
markers with childhood type 1 diabetes mellitus revealed by a long questionnaire on early life
exposures and lifestyle in a case-control study." BMC Public Health 16(1): 1021.
47. ■ Bayry, J. and J. F. Gautier (2016). "Regulatory T Cell Immunotherapy for Type 1 Diabetes: A
Step Closer to Success?" Cell Metab 23(2): 231-233. (IF:18)
48. Baz, B., J. P. Riveline and J. F. Gautier (2016). "ENDOCRINOLOGY OF PREGNANCY: Gestational
diabetes mellitus: definition, aetiological and clinical aspects." Eur J Endocrinol 174(2): R43-51.
49. Bellanné-Chantelot C, Coste J, Ciangura C, Fonfrède M, Saint-Martin C, Bouché C, Sonnet E,
Valéro R, Lévy DJ, Dubois-Laforgue D, Timsit J; Monogenic Diabetes Study Group of the Société
Francophone du Diabète (SFD) (2016). High-sensitivity C-reactive protein does not improve the
4
Group D: evaluation campaign 2017 - 2018
Department for the evaluation of research unitsResearch unit evaluation
November 2016
differential diagnosis of HNF1A-MODY and familial young-onset type 2 diabetes: A grey zone
analysis. Diabetes Metab. 42(1):33-7. doi: 10.1016/j.diabet.2015.02.001. Epub 2015 Mar 6.
50. Brown, R. J., J. L. Chan, E. S. Jaffe, E. Cochran, A. M. DePaoli, J. F. Gautier, C. Goujard, C.
Vigouroux and P. Gorden (2016). "Lymphoma in acquired generalized lipodystrophy." Leuk
Lymphoma 57(1): 45-50.
51. Chon, S. and J. F. Gautier (2016). "An Update on the Effect of Incretin-Based Therapies on beta-
Cell Function and Mass." Diabetes Metab J 40(2): 99-114.
52. Desposito D, Chollet C, Taveau C, Potier L, Descamps V, Alhenc-Gelas F, Roussel R, Bouby N,
Waeckel L (2016). Improvement of skin wound healing in diabetic mice by kinin B2 receptor
blockade. Clin Sc 130(1):45-56
53. Desposito D, Waeckel L, Potier L, Richer C, Roussel R, Bouby N, Alhenc-Gelas F (2016).
Kallikrein(K1)-kinin-kininase (ACE) and end-organ damage in ischemia and diabetes: therapeutic
implications. Biol Chem. 1;397(12):1217-1222.
54. Desposito, D., C. Chollet, C. Taveau, V. Descamps, F. Alhenc-Gelas, R. Roussel, N. Bouby and L.
Waeckel (2016). "Improvement of skin wound healing in diabetic mice by kinin B2 receptor
blockade." Clin Sci (Lond) 130(1): 45-56.
55. Ebou, M. H., A. Singh-Estivalet, J. M. Launay, J. Callebert, F. Tronche, P. Ferre, J. F. Gautier, G.
Guillemain, B. Breant, B. Blondeau and J. P. Riveline (2016). "Correction: Glucocorticoids Inhibit
Basal and Hormone-Induced Serotonin Synthesis in Pancreatic Beta Cells." PLoS One 11(5):
e0155174.
56. ■ Fan R, A Toubal, S Goni, K Drareni, Z Huang, F Alzaid, R Ballaire, P Ancel, N Liang, A
Damdimopoulos, I Hainault, A Soprani, J Aron-Wisnewsky, F Foufelle, T Lawrence, JF Gautier, N
Venteclef and E. Treuter (2016). Loss of the co-repressor GPS2 sensitizes macrophage activation
upon metabolic stress induced by obesity and type 2 diabetes. Nat Med 22(7): 780-791. (IF:27)
57. Fond G, Gavaret M, Vidal C, Brunel L, Riveline JP, Micoulaud-Franchi JA, Domenech P (2016).
(Mis)use of Prescribed Stimulants in the Medical Student Community: Motives and Behaviors: A
Population-Based Cross-Sectional Study. Medicine (Baltimore). 95(16):e3366. doi:
10.1097/MD.0000000000003366.
58. Gautier, J. F., P. Monguillon, O. Verier-Mine, P. Valensi, B. Fiquet, S. Dejager and B. Charbonnel
(2016). "Which oral antidiabetic drug to combine with metformin to minimize the risk of
hypoglycemia when initiating basal insulin?: A randomized controlled trial of a DPP4 inhibitor
versus insulin secretagogues." Diabetes Res Clin Pract 116: 26-28.
59. Gellen, B., N. Thorin-Trescases, P. Sosner, E. Gand, P. J. Saulnier, S. Ragot, M. Fraty, S. Laugier, G.
Ducrocq, D. Montaigne, P. Llaty, V. Rigalleau, P. Zaoui, J. M. Halimi, R. Roussel, E. Thorin and S.
Hadjadj (2016). "ANGPTL2 is associated with an increased risk of cardiovascular events and
death in diabetic patients." Diabetologia 59(11): 2321-2330.
60. Hadjadj S, Cariou B, Fumeron F, Gand E, Charpentier G, Roussel R, Kasmi A-A, Gautier JF,
Mohammedi K, Gourdy P, Saulnier PJ, Feigerlova E, Marre M (2016). Death, End-Stage Renal
Disease and renal function decline in patients with diabetic nephropathy in French cohorts of
type 1 and type 2 diabetes. Diabetologia; 59:208–216.
61. Hadjadj, S., B. Cariou, F. Fumeron, E. Gand, G. Charpentier, R. Roussel, A. A. Kasmi, J. F. Gautier,
K. Mohammedi, P. Gourdy, P. J. Saulnier, E. Feigerlova, M. Marre, J. D. N. C. R. I. French, S. s.
group and D. s. group (2016). "Death, end-stage renal disease and renal function decline in
patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetes."
Diabetologia 59(1): 208-216. (IF:6.2)
62. Hansel, B., D. Bonnefont-Rousselot, A. Orsoni, R. Bittar, P. Giral, R. Roussel, M. Marre, K.
Mohammedi, E. Bruckert, M. J. Chapman and A. Kontush (2016). "Lifestyle intervention
enhances high-density lipoprotein function among patients with metabolic syndrome only at
normal low-density lipoprotein cholesterol plasma levels." J Clin Lipidol 10(5): 1172-1181.
63. Hasni Ebou M, Singh-Estivalet A, Launay JM, Callebert J, Tronche F, Ferré P, Gautier JF,
Guillemain G, Bréant B, Blondeau B, Riveline JP (2016). Glucocorticoids Inhibit Basal and
Hormone-Induced Serotonin Synthesis in Pancreatic Beta Cells. PLoS One.;11(2):e0149343. doi:
5
Group D: evaluation campaign 2017 - 2018
Department for the evaluation of research unitsResearch unit evaluation
November 2016
10.1371/journal.pone.0149343. eCollection 2016.
64. Joubert M, Baillot-Rudoni S, Catargi B, Charpentier G, Esvant A, Franc S, Guerci B, Guilhem I,
Melki V, Merlen E, Penfornis A, Renard E, Riveline JP, Schaepelynck P, Sola-Gazagnes A, Hanaire
H; Société Francophone du Diabète (SFD); Société Française d’Endocrinologie (SFE); EVAluation
dans le Diabète des Implants ACtifs Group (EVADIAC) (2016). Indication, organization, practical
implementation and interpretation guidelines for retrospective CGM recording: A French
position statement. Diabetes Metab.41 (6):498-508. doi: 10.1016/j.diabet.2015.07.001.
65. Lamri A, Bonnefond A, Meyre D, Balkau B, Roussel R, Marre M, Froguel P, Fumeron F and the
D.E.S.I.R. study Group (2016). Interaction between GPR120 p.R270H loss-of-function variant and
dietary fat intake on incident type 2 diabetes risk in the D.E.S.I.R. study. Nutr Metab Cardiovasc
Dis; 26, 931-936
66. Larifla, L., C. Rambhojan, M. O. Joannes, S. Maimaitiming-Madani, J. P. Donnet, T. Marianne-
Pepin, R. Chout, R. Roussel and L. Foucan (2016). "Gene Polymorphisms of FABP2, ADIPOQ and
ANP and Risk of Hypertriglyceridemia and Metabolic Syndrome in Afro-Caribbeans." PLoS One
11(9): e0163421.
67. Lu Y … Fumeron F… Kilpeläinen TO, Loos RJF (2016). New loci for body fat percentage reveal link
between adiposity and cardiometabolic disease risk. Nat Commun; 7:10495
68. Mohammedi K, Compaoros RJ, Potier L, Belhatem N, Feron M, Matallah N, Travert F, Hansel B,
Velho G, Roussel R, Hallab M, Marre M (2016). Outpatient measurement of arterial stiffness in
patients with type 2 diabetes and obesity. J Diabetes. doi: 10.1111/1753-0407.12405.
69. Mohammedi K, Patente TA, Bellili-Muñoz N, Driss F, Le Nagard H, Fumeron F, Roussel R, Hadjadj
S, Lúcia Corrêa-Giannella, Marre M, Velho G (2016). Glutathione peroxidase-1 gene (GPX1)
variants, oxidative stress and risk of kidney complications in people with type 1 diabetes.
Metabolism; 65:12-19 (IF:5)
70. Mohammedi K, Potier L, Belhatem N, Matallah N, Hadjadj S, Roussel R, Marre M, Velho G
(2016). Lower-extremity amputation as a marker for renal and cardiovascular events and
mortality in patients with long standing type 1 diabetes. Cardiovasc Diabetol. 7;15(1):5.
71. Mohammedi K, Potier L, Fran Li K, Diabetol. 7;15(1):5.7;15(1):5.ker for renal and cardiovascular
events and mortality in patients with long standing type aribbeans." PLoVelho G, Tubach F,
Roussel R, Duprl RF, Diabetol. 7;15(1):5.7;15(1):5.ker for renal and cardiovascular events and
mortality in patients with long standing type aribbeans." PLoS One k inmplants ACtifs Group
(EVADIACJ Foot Ankle Res. 22;9(1):34.
72. Mohammedi, K., A. Compaore, L. Potier, N. Belhatem, M. Feron, N. Matallah, F. Travert, B.
Hansel, G. Velho, R. Roussel, M. Hallab and M. Marre (2017). "Outpatient measurement of
arterial stiffness in patients with type 2 diabetes and obesity." J Diabetes 9(3): 237-242.
73. Mohammedi, K., L. Potier, M. Francois, D. Dardari, M. Feron, E. Nobecourt-Dupuy, M. Dolz, R.
Ducloux, A. Chibani, D. F. Eveno, T. Crea Avila, A. Sultan, L. Baillet-Blanco, V. Rigalleau, G. Velho,
F. Tubach, R. Roussel, J. C. Dupre, D. Malgrange and M. Marre (2016). "The evaluation of off-
loading using a new removable oRTHOsis in DIABetic foot (ORTHODIAB) randomized controlled
trial: study design and rational." J Foot Ankle Res 9(1): 34.
74. Mohammedi, K., L. Potier, N. Belhatem, N. Matallah, S. Hadjadj, R. Roussel, M. Marre and G.
Velho (2016). "Lower-extremity amputation as a marker for renal and cardiovascular events and
mortality in patients with long standing type 1 diabetes." Cardiovasc Diabetol 15: 5.
75. Moutairou A, Roussel R, Charbonnel B, El Boustany R, Nicolas A, Leye A, Mohammedi K, Marre
M, Detournay B, Potier L (2016). Short-term effect of severe hypoglycaemia on glycaemic
control in the Diabetes Control and Complications Trial. Diabetes Metab. pii: S1262-
3636(16)30476-1.
76. Ragot S, Saulnier PJ, Velho G, Gand E, de Hauteclocque A, Slaoui Y, Potier L, Sosner P, Halimi JM,
Zaoui P, Rigalleau V, Fumeron F, Roussel R, Marre M, Hadjadj S; SURDIAGENE; DIABHYCAR study
groups (2016). Dynamic Changes in Renal Function Are Associated With Major Cardiovascular
Events in Patients With Type 2 Diabetes. Diabetes Care; 39:1259-1266
6
Group D: evaluation campaign 2017 - 2018
Department for the evaluation of research unitsResearch unit evaluation
November 2016
77. Roussel R, El Boustany R, Bouby N, Potier L, Fumeron F, Mohammedi K, Balkau B, Tichet J, Bankir
L, Marre M, Velho G (2016). Plasma copeptin, AVP gene variants, and incidence of type 2
diabetes in a cohort from the community. J Clin Endocrinol Metab; 101:2432-2439 (IF: 5.5)
78. Roussel, R., A. Natali, B. Balkau, K. Hojlund, G. Sanchez, J. J. Nolan, A. Mari, M. Kozakova and F.
Bonnet (2016). "Beta-cell function is associated with carotid intima-media thickness
independently of insulin resistance in healthy individuals." J Hypertens 34(4): 685-691.
79. Roussel, R., B. Charbonnel, M. Behar, J. Gourmelen, C. Emery and B. Detournay (2016).
"Persistence with Insulin Therapy in Patients with Type 2 Diabetes in France: An Insurance
Claims Study." Diabetes Ther 7(3): 537-549.
80. Roussel, R., L. Martinez, T. Vandebrouck, H. Douik, P. Emiel, M. Guery, B. Hunt and W. J.
Valentine (2016). "Evaluation of the long-term cost-effectiveness of liraglutide therapy for
patients with type 2 diabetes in France." J Med Econ 19(2): 121-134.
81. Roussel, R., R. El Boustany, N. Bouby, L. Potier, F. Fumeron, K. Mohammedi, B. Balkau, J. Tichet,
L. Bankir, M. Marre and G. Velho (2016). "Plasma Copeptin, AVP Gene Variants, and Incidence of
Type 2 Diabetes in a Cohort From the Community." J Clin Endocrinol Metab 101(6): 2432-2439.
(IF: 5.5)
82. Steg, P. G. and R. Roussel (2016). "Randomized Trials to Evaluate Cardiovascular Safety of
Antihyperglycemic Medications: A Worthwhile Effort?" Circulation 134(8): 571-573. (IF: 14.4)
83. Vatier C, Fetita S, Boudou P, Tchankou C, Deville L, Riveline JP, Young J, Mathivon L, Travert F,
Morin D, Cahen J, Lascols O, Andreelli F, Reznik Y, Mongeois E, Madelaine I, Vantyghem M,
Gautier JF, Vigouroux C (2016). One-year metreleptin improves insulin secretion in patients with
diabetes linked to genetic lipodystrophic syndromes. Diabetes Obes Metab. 18(7):693-7. doi:
10.1111/dom.12606. (IF: 6.4)
84. Velho G, El Boustany R, Lefèvre G, Mohammedi K; Fumeron F, Potier L, Bankir L, Bouby N,
Hadjadj S, Marre M, Roussel R. Plasma copeptin, kidney outcomes, ischemic heart disease and
all-cause mortality in people with long-standing type 1 diabetes. Diabetes Care. 39(12):2288-
2295 (IF: 8.9)
85. Yengo, L., A. Arredouani, M. Marre, R. Roussel, M. Vaxillaire, M. Falchi, A. Haoudi, J. Tichet, D. E.
S. I. R. S. Group, B. Balkau, A. Bonnefond and P. Froguel (2016). "Impact of statistical models on
the prediction of type 2 diabetes using non-targeted metabolomics profiling." Mol Metab 5(10):
918-925.
86. Zeller, M., M. Labalette-Bart, J. M. Juliard, L. Potier, L. J. Feldman, P. G. Steg, Y. Cottin and R.
Roussel (2016). "Metformin and contrast-induced acute kidney injury in diabetic patients
treated with primary percutaneous coronary intervention for ST segment elevation myocardial
infarction: Amulticenter study." Int J Cardiol 220: 137-142. (IF: 5)
2015
87. Ayina Ayina, C. N., E. Sobngwi, M. Essouma, J. J. Noubiap, P. Boudou, L. S. Etoundi Ngoa and J. F.
Gautier (2015). "Osteoprotegerin in relation to insulin resistance and blood lipids in sub-Saharan
African women with and without abdominal obesity." Diabetol Metab Syndr 7: 47.
88. Balti, E. V., M. C. Ngo-Nemb, E. Lontchi-Yimagou, B. Atogho-Tiedeu, V. S. Effoe, E. A. Akwo, M. Y.
Dehayem, J. C. Mbanya, J. F. Gautier and E. Sobngwi (2015). "Association of HLA class II markers
with autoantibody-negative ketosis-prone atypical diabetes compared to type 2 diabetes in a
population of sub-Saharan African patients." Diabetes Res Clin Pract 107(1): 31-36.
89. Bankir L, Plischke M, Bouby N, Haas M (2015). Urine Osmolarity and Risk of Dialysis Initiation in
a CKD Cohort. Ann Nutr Metab. 66 Suppl 3:14-7. doi: 10.1159/000381240.
90. Bankir, L., R. Roussel and N. Bouby (2015). "Protein- and diabetes-induced glomerular
hyperfiltration: role of glucagon, vasopressin, and urea." Am J Physiol Renal Physiol 309(1): F2-
23.
91. Belhatem, N., K. Mohammedi, F. Rouzet, N. Matallah, A. Al Baloshi, F. Travert, G. Velho, R.
Roussel, D. Le Guludec, M. Marre and B. Hansel (2015). "Impact of morbid obesity on the kidney
function of patients with type 2 diabetes." Diabetes Res Clin Pract 108(1): 143-149.
7
Group D: evaluation campaign 2017 - 2018
Department for the evaluation of research unitsResearch unit evaluation
November 2016
92. ■ Besseiche, A., J. P. Riveline, J. F. Gautier, B. Breant and B. Blondeau (2015). "Metabolic roles
of PGC-1alpha and its implications for type 2 diabetes." Diabetes Metab 41(5): 347-357.
93. Bonnefond A, Lamri A, Leloire A, Vaillant E, Roussel R, Lévy-Marchal C, Weill J, Galan P, Hercberg
S, Ragot S, Hadjadj S, Charpentier G, Balkau B, Marre M, Fumeron F, Froguel P (2015).
Contribution of the low-frequency loss-of-function p.R270H mutation in FFAR4 (GPR120) to
increased fasting plasma glucose levels. J Med Genet; 52:595-598
94. Bonnefond A, Yengo L, Le May C, Fumeron F, Marre M, Balkau B, Charpentier G, Franc S, Froguel
P, Cariou B (2015). The loss-of-function PCSK9 p.R46L genetic variant does not alter glucose
homeostasis. Diabetologia; 58:2051–2055
95. Bouche, C. H., J. P. Garnier, S. P. Choukem and J. F. Gautier (2015). "Falsely elevated capillary
glucose and ketone levels and use of skin lightening creams." BMJ 351: h3879. (IF: 19.6)
96. Brown, R. J., J. L. Chan, E. S. Jaffe, E. Cochran, A. M. DePaoli, J. F. Gautier, C. Goujard, C.
Vigouroux and P. Gorden (2016). "Lymphoma in acquired generalized lipodystrophy." Leuk
Lymphoma 57(1): 45-50.
97. Choukem, S. P., E. Sobngwi, J. P. Garnier, S. Letellier, F. Mauvais-Jarvis, F. Calvo and J. F. Gautier
(2015). "Hyperglycaemia per se does not affect erythrocyte glucose-6-phosphate
dehydrogenase activity in ketosis-prone diabetes." Diabetes Metab 41(4): 326-330.
98. Da Silva MA, Dugravot A, Balkau B, Roussel R, Fumeron F, Elbaz A, Canonico M, Singh-Manoux A,
Nabi H, and the D.E.S.I.R. Study Group (2015). Antidepressant medication use and trajectories of
fasting plasma glucose, glycated hemoglobin, β-cell function, and insulin sensitivity: a 9-year
longitudinal study of the D.E.S.I.R. cohort. Int J Epidemiol;44:1927-1940
99. Dalmas, E. and N. Venteclef (2015). The adipose tissue macrophages: new modulators of fat
mass repartition in obesity. Med Sci (Paris) 31(12): 1080-1082.
100. ■ Dalmas*, E., A. Toubal*, F. Alzaid*, K. Blazek, H. L. Eames, K. Lebozec, M. Pini, I.
Hainault, E. Montastier, R. G. Denis, P. Ancel, A. Lacombe, Y. Ling, O. Allatif, C. Cruciani-
Guglielmacci, S. Andre, N. Viguerie, C. Poitou, V. Stich, A. Torcivia, F. Foufelle, S. Luquet, J. Aron-
Wisnewsky, D. Langin, K. Clement, I. A. Udalova and N. Venteclef (2015). Irf5 deficiency in
macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during
obesity. Nat Med 21(6): 610-618. (IF:27)
101. Desposito D, Potier L, Chollet C, Gobeil F, Roussel R, Alhenc-Gelas F, Bouby N, Waeckel L
(2015). Kinin receptor agonism restores hindlimb postischemic neovascularization capacity in
diabetic mice. J Pharmacol Exp Ther. Feb;352(2):218-26
102. Dina, C., N. Bouatia-Naji, N. Tucker, F. N. Delling, K. Toomer, R. Durst, M. Perrocheau, L.
Fernandez-Friera, J. Solis, P. investigators, T. Le Tourneau, M. H. Chen, V. Probst, Y. Bosse, P.
Pibarot, D. Zelenika, M. Lathrop, S. Hercberg, R. Roussel, E. J. Benjamin, F. Bonnet, S. H. Lo, E.
Dolmatova, F. Simonet, S. Lecointe, F. Kyndt, R. Redon, H. Le Marec, P. Froguel, P. T. Ellinor, R. S.
Vasan, P. Bruneval, R. R. Markwald, R. A. Norris, D. J. Milan, S. A. Slaugenhaupt, R. A. Levine, J. J.
Schott, A. A. Hagege, M. V. P. France, X. Jeunemaitre and M. N. Leducq Transatlantic (2015).
"Genetic association analyses highlight biological pathways underlying mitral valve prolapse."
Nat Genet 47(10): 1206-1211.
103. Emerging Risk Factors, C., E. Di Angelantonio, S. Kaptoge, D. Wormser, P. Willeit, A. S.
Butterworth, N. Bansal, L. M. O'Keeffe, P. Gao, A. M. Wood, S. Burgess, D. F. Freitag, L. Pennells,
S. A. Peters, C. L. Hart, L. L. Haheim, R. F. Gillum, B. G. Nordestgaard, B. M. Psaty, B. B. Yeap, M.
W. Knuiman, P. J. Nietert, J. Kauhanen, J. T. Salonen, L. H. Kuller, L. A. Simons, Y. T. van der
Schouw, E. Barrett-Connor, R. Selmer, C. J. Crespo, B. Rodriguez, W. M. Verschuren, V. Salomaa,
K. Svardsudd, P. van der Harst, C. Bjorkelund, L. Wilhelmsen, R. B. Wallace, H. Brenner, P.
Amouyel, E. L. Barr, H. Iso, A. Onat, M. Trevisan, R. B. D'Agostino, Sr., C. Cooper, M. Kavousi, L.
Welin, R. Roussel, F. B. Hu, S. Sato, K. W. Davidson, B. V. Howard, M. J. Leening, A. Rosengren,
M. Dorr, D. J. Deeg, S. Kiechl, C. D. Stehouwer, A. Nissinen, S. Giampaoli, C. Donfrancesco, D.
Kromhout, J. F. Price, A. Peters, T. W. Meade, E. Casiglia, D. A. Lawlor, J. Gallacher, D. Nagel, O.
H. Franco, G. Assmann, G. R. Dagenais, J. W. Jukema, J. Sundstrom, M. Woodward, E. J. Brunner,
K. T. Khaw, N. J. Wareham, E. A. Whitsel, I. Njolstad, B. Hedblad, S. Wassertheil-Smoller, G.
8
Group D: evaluation campaign 2017 - 2018
Department for the evaluation of research unitsResearch unit evaluation
November 2016
Engstrom, W. D. Rosamond, E. Selvin, N. Sattar, S. G. Thompson and J. Danesh (2015).
"Association of Cardiometabolic Multimorbidity With Mortality." JAMA 314(1): 52-60.
104. Frisdal, E., S. Le Lay, H. Hooton, L. Poupel, M. Olivier, R. Alili, W. Plengpanich, E. F.
Villard, S. Gilibert, M. Lhomme, A. Superville, L. Miftah-Alkhair, M. J. Chapman, G. M. Dallinga-
Thie, N. Venteclef, C. Poitou, J. Tordjman, P. Lesnik, A. Kontush, T. Huby, I. Dugail, K. Clement,
M. Guerin and W. Le Goff (2015). Adipocyte ATP-binding cassette G1 promotes triglyceride
storage, fat mass growth, and human obesity. Diabetes 64(3): 840-855.
105. Gaborit, B., N. Venteclef, P. Ancel, V. Pelloux, V. Gariboldi, P. Leprince, J. Amour, S. N.
Hatem, E. Jouve, A. Dutour and K. Clement (2015). Human epicardial adipose tissue has a
specific transcriptomic signature depending on its anatomical peri-atrial, peri-ventricular, or
peri-coronary location. Cardiovasc Res 108(1): 62-73.
106. ■ Gautier JF, Porcher R, Abi Khalil C, Bellili-Munoz N, Fetita LS, Travert F, Choukem SP,
Riveline JP, Hadjadj S, Larger E, Boudou P, Blondeau B, Roussel R, Ferré P, Ravussin E, Rouzet F,
Marre M (2015). Kidney Dysfunction in Adult Offspring Exposed In Utero to Type 1 Diabetes Is
Associated with Alterations in Genome-Wide DNA Methylation. PLoS One. 10;10(8):e0134654.
doi: 10.1371/journal.pone.0134654. eCollection 2015. (IF : 3.2)
107. Gautier, J. F., L. Martinez, A. Penfornis, E. Eschwege, G. Charpentier, B. Huret, S. Madani
and P. Gourdy (2015). "Effectiveness and Persistence with Liraglutide Among Patients with Type
2 Diabetes in Routine Clinical Practice--EVIDENCE: A Prospective, 2-Year Follow-Up,
Observational, Post-Marketing Study." Adv Ther 32(9): 838-853.
108. Germain, M., M. G. Pezzolesi, N. Sandholm, A. J. McKnight, K. Susztak, M. Lajer, C.
Forsblom, M. Marre, H. H. Parving, P. Rossing, I. Toppila, J. Skupien, R. Roussel, Y. A. Ko, N. Ledo,
L. Folkersen, M. Civelek, A. P. Maxwell, D. A. Tregouet, P. H. Groop, L. Tarnow and S. Hadjadj
(2015). "SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage
genome-wide association study in patients with type 1 diabetes." Diabetologia 58(3): 543-548.
109. Hansel, B., R. Roussel, V. Diguet, A. Deplaude, M. J. Chapman and E. Bruckert (2015).
"Relationships between consumption of alcoholic beverages and healthy foods: the French
supermarket cohort of 196,000 subjects." Eur J Prev Cardiol 22(2): 215-222.
110. Hansel, B., R. Roussel, Y. Elbez, M. Marre, M. Krempf, Y. Ikeda, K. A. Eagle, M. Elisaf, D. L.
Bhatt, P. G. Steg and R. R. Investigators (2015). "Cardiovascular risk in relation to body mass
index and use of evidence-based preventive medications in patients with or at risk of
atherothrombosis." Eur Heart J 36(40): 2716-2728.
111. Leveziel, N., S. Ragot, E. Gand, O. Lichtwitz, J. M. Halimi, J. Gozlan, P. Gourdy, M. F.
Robert, D. Dardari, M. Boissonnot, R. Roussel, X. Piguel, O. Dupuy, F. Torremocha, P. J. Saulnier,
R. Marechaud, S. Hadjadj and D. N. s. group (2015). "Association Between Diabetic Macular
Edema and Cardiovascular Events in Type 2 Diabetes Patients: A Multicenter Observational
Study." Medicine (Baltimore) 94(33): e1220.
112. Magalhaes, I., K. Pingris, C. Poitou, S. Bessoles, N. Venteclef, B. Kiaf, L. Beaudoin, J. Da
Silva, O. Allatif, J. Rossjohn, L. Kjer-Nielsen, J. McCluskey, S. Ledoux, L. Genser, A. Torcivia, C.
Soudais, O. Lantz, C. Boitard, J. Aron-Wisnewsky, E. Larger, K. Clement and A. Lehuen (2015).
Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients. J Clin Invest
125(4): 1752-1762.
113. Mohammedi K, Bellili-Muñoz N, Marklund SL, Driss F, Le Nagard H, Patente TA, Fumeron
F, Roussel R, Hadjadj S, Marre M, Velho G (2015). Plasma extracellular superoxide dismutase
concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause
mortality in people with type 1 and type 2 diabetes. Cardiovasc Diabetologia;14:845
114. Monseu, M., E. Gand, P. J. Saulnier, S. Ragot, X. Piguel, P. Zaoui, V. Rigalleau, R.
Marechaud, R. Roussel, S. Hadjadj, J. M. Halimi and S. S. Group (2015). "Acute Kidney Injury
Predicts Major Adverse Outcomes in Diabetes: Synergic Impact With Low Glomerular Filtration
Rate and Albuminuria." Diabetes Care 38(12): 2333-2340.
9
Group D: evaluation campaign 2017 - 2018
Department for the evaluation of research unitsResearch unit evaluation
November 2016
115. Nicolas A, Fatima S, Lamri A, Bellili-Munoz N, Halimi JM, Saulnier PJ, Hadjadj S, Velho G,
Marre M, Roussel R, Fumeron F (2015). ABCG8 polymorphisms and renal disease in type 2
diabetic patients. Metabolism 2015; 64:713-719
116. Patente TA, Mohammedi K, Bellili-Muñoz N, Driss F, Sanchez M, Fumeron F, Roussel R,
Hadjadj S, Corrêa-Giannella ML, Marre M, Velho G (2015). Allelic variations in the CYBA gene of
NADPH oxidase and risk of kidney complications in patients with type 1 diabetes. Free Radic Biol
Med; 86:16–24
117. Potier L, El Batti S, Mohammedi K (2015). A Paclitaxel-Coated Balloon for
Femoropopliteal Artery Disease. N Engl J Med. Oct 29;373(18):1784-5. (IF: 59.5)
118. Potier L, Matallah N, Mohammedi K (2015). Coronary artery disease screening using
coronary computed tomography angiography. JAMA. Mar 24-31;313(12):1267. (IF: 37.7)
119. Potier L, Roussel R, Labreuche J, Marre M, Cacoub P, Roronary artery dPWF, Goto S,
Bhatt DL, Steg PG, for the REACH Investigators (2015). Interaction between diabetes and a high
Ankle-Brachial Index on mortality risk. Eur J Prev Cardiol. 22(5):615-21.
120. Roussel R, Matallah N, Bouby N, El Boustany R, Potier L, Fumeron F, Mohammedi K,
Balkau B, Marre M, Bankir L, Velho G (2015). Plasma copeptin and decline in renal function in a
cohort from the community: the prospective D.E.S.I.R. Study. Am J Nephrol;42:107-114
121. Taveau C, Chollet C, Waeckel L, Desposito D, Bichet DG, Arthus MF, Magnan C, Philippe
E, Paradis V, Foufelle F, Hainault I, Enhorning S, Velho G, Roussel R, Bankir L, Melander O, Bouby
N (2015). Vasopressin and hydration play a major role in the development of glucose
intolerance and hepatic steatosis in obese rats. Diabetologia, 58(5):1081-90
122. ■ Urbanet, R., A. Nguyen Dinh Cat, A. Feraco, N. Venteclef, S. El Mogrhabi, C. Sierra-
Ramos, D. Alvarez de la Rosa, G. K. Adler, D. Quilliot, P. Rossignol, F. Fallo, R. M. Touyz and F.
Jaisser (2015). Adipocyte Mineralocorticoid Receptor Activation Leads to Metabolic Syndrome
and Induction of Prostaglandin D2 Synthase. Hypertension 66(1): 149-157.
123. Velho G, Ragot S, Mohammedi K, Gand E, Fraty M, Fumeron F, Bellili-Munoz N, Bouby N,
Potier L,, Alhenc-Gelas F, Marre M, Hadjadj S, Roussel R (2015). Plasma adrenomedullin, allelic
variation in the ADM gene and kidney disease in people with type 2 diabetes. Diabetes; 64:3262-
72 (I.F.:8.6)
124. Venteclef, N., V. Guglielmi, E. Balse, B. Gaborit, A. Cotillard, F. Atassi, J. Amour, P.
Leprince, A. Dutour, K. Clement and S. N. Hatem (2015). Human epicardial adipose tissue
induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur Heart J
36(13): 795-805a. (IF: 15.2)
2014
125. Ahren, B., J. F. Gautier, R. Berria, W. Stager, R. Aronson and C. J. Bailey (2014).
"Pronounced reduction of postprandial glucagon by lixisenatide: a meta-analysis of randomized
clinical trials." Diabetes Obes Metab 16(9): 861-868.
126. Aveline, C., A. L. Roux, H. L. Hetet, J. F. Gautier, P. Vautier, F. Cognet and F. Bonnet
(2014). "Pain and recovery after total knee arthroplasty: a 12-month follow-up after a
prospective randomized study evaluating Nefopam and Ketamine for early rehabilitation." Clin J
Pain 30(9): 749-754.
127. Ayina Ayina, C. N., P. Boudou, I. Fidaa, E. V. Balti, E. Sobngwi, L. S. Etoundi Ngoa and J. F.
Gautier (2014). "Osteoprotegerin is not a determinant of metabolic syndrome in sub-Saharan
Africans after age adjustment." Ann Endocrinol (Paris) 75(3): 165-170.
128. Bouby, N., W. F. Clark, R. Roussel, C. Taveau and C. J. Wang (2014). "Hydration and
kidney health." Obes Facts 7 Suppl 2: 19-32.
129. Chon, S., J. P. Riveline, B. Blondeau and J. F. Gautier (2014). "Incretin-based therapy and
pancreatic beta cells." Diabetes Metab 40(6): 411-422.
130. Choukem, S. P., C. Fabreguettes, E. Akwo, R. Porcher, J. L. Nguewa, C. Bouche, F. F. Kaze,
A. P. Kengne, P. Vexiau, J. C. Mbanya, E. Sobngwi and J. F. Gautier (2014). "Influence of
10
Group D: evaluation campaign 2017 - 2018
Department for the evaluation of research unitsResearch unit evaluation
November 2016
migration on characteristics of type 2 diabetes in sub-Saharan Africans." Diabetes Metab 40(1):
56-60.
131. Dalmas, E., N. Venteclef, C. Caer, C. Poitou, I. Cremer, J. Aron-Wisnewsky, S. Lacroix-
Desmazes, J. Bayry, S. V. Kaveri, K. Clement, S. Andre and M. Guerre-Millo (2014). T cell-derived
IL-22 amplifies IL-1beta-driven inflammation in human adipose tissue: relevance to obesity and
type 2 diabetes. Diabetes 63(6): 1966-1977. (IF: 8.6)
132. de Hauteclocque, A., S. Ragot, Y. Slaoui, E. Gand, A. Miot, P. Sosner, J. M. Halimi, P.
Zaoui, V. Rigalleau, R. Roussel, P. J. Saulnier, S. Hadjadj Samy and S. S. group (2014). "The
influence of sex on renal function decline in people with Type 2 diabetes." Diabet Med 31(9):
1121-1128.
133. ■ Diawara, M. R., C. Hue, S. P. Wilder, N. Venteclef, J. Aron-Wisnewsky, J. Scott, K.
Clement, D. Gauguier and S. Calderari (2014). Adaptive expression of microRNA-125a in adipose
tissue in response to obesity in mice and men. PLoS One 9(3): e91375.
134. Feldman, L., F. Tubach, J. M. Juliard, D. Himbert, G. Ducrocq, E. Sorbets, K. Triantafyllou,
A. Kerner, H. Abergel, M. G. Huisse, R. Roussel, M. Esposito-Farese, P. G. Steg and N. Ajzenberg
(2014). "Impact of diabetes mellitus and metabolic syndrome on acute and chronic on-
clopidogrel platelet reactivity in patients with stable coronary artery disease undergoing drug-
eluting stent placement." Am Heart J 168(6): 940-947 e945.
135. Foucan L, Maimaitiming S, Larifla L, Hedreville S, Deloumeaux J, Joannes MO, Blanchet-
Deverly A, Velayoudom FL, Aubert R, Salamon R, Donnet JP, Fumeron F (2014). ADIPOQ variants,
adiponectin multimeric forms and cardiometabolic risk in type 2 diabetic patients of African
ancestry. J Diab Invest 5: 192–198
136. Hus-Citharel A, Bodineau L, Frugiere A, Joubert F, Bouby N, Llorens-Cortes C (2014).
Apelin counteracts vasopressin-induced water reabsorption via crosstalk between apelin and
vasopressin receptor signaling pathways in the rat collecting duct. Endocrinology 155(11):4483-
93.
137. Jakobsson, T., L. L. Vedin, T. Hassan, N. Venteclef, D. Greco, M. D'Amato, E. Treuter, J. A.
Gustafsson and K. R. Steffensen (2014). The oxysterol receptor LXRbeta protects against DSS-
and TNBS-induced colitis in mice. Mucosal Immunol 7(6): 1416-1428.
138. Lafarge, J. C., M. Pini, V. Pelloux, G. Orasanu, G. Hartmann, N. Venteclef, T. Sulpice, G. P.
Shi, K. Clement and M. Guerre-Millo (2014). Cathepsin S inhibition lowers blood glucose levels in
mice. Diabetologia 57(8): 1674-1683.
139. Mohammedi K, Maimaitiming S, Emery N, Bellili-Muñoz N, Roussel R, Fumeron F,
Hadjadj S, Marre M, Velho G (2014). Manganese superoxide dismutase (SOD2) polymorphisms,
plasma advanced oxidation protein products (AOPP) concentration and risk of kidney
complications in subjects with type 1 diabetes. PLOS One 9(5):e96916.
140. Mohammedi, K., C. Abi Khalil, S. Olivier, I. Benabad, R. Roussel and M. Marre (2014).
"Paraneoplastic hypoglycemia in a patient with a malignant solitary fibrous tumor." Endocrinol
Diabetes Metab Case Rep 2014: 140026.
141. Potier L, Waeckel L, Fumeron F, Bodin S, Fysekidis M, Chollet C, Bellili N, Bonnet F, Gusto
G, Velho G, Marre M, Alhenc-Gelas F, Roussel R, Bouby N, the DESIR study group (2014). Tissue
kallikrein deficiency, insulin resistance and diabetes in mouse and man. J Endocrinol 221:305-
316 (I.F. :4.5)
142. Raccah, D., J. Lin, E. Wang, M. Germe, R. Perfetti, R. C. Bonadonna, P. de Pablos-Velasco,
R. Roussel and J. Rosenstock (2014). "Once-daily prandial lixisenatide versus once-daily rapid-
acting insulin in patients with type 2 diabetes mellitus insufficiently controlled with basal insulin:
analysis of data from five randomized, controlled trials." J Diabetes Complications 28(1): 40-44.
143. Rea, D., T. Mirault, T. Cluzeau, J. F. Gautier, F. Guilhot, H. Dombret and E. Messas (2014).
"Early onset hypercholesterolemia induced by the 2nd-generation tyrosine kinase inhibitor
nilotinib in patients with chronic phase-chronic myeloid leukemia." Haematologica 99(7): 1197-
1203.
11
Group D: evaluation campaign 2017 - 2018
Department for the evaluation of research unitsResearch unit evaluation
November 2016
144. Roussel R, Fezeu L, Marre M, Velho G, Fumeron F, Jungers P, Lantieri O, Balkau B, Bouby
N, Bankir L, Bichet DG, and the D.E.S.I.R. Study Group (2014). Comparison between copeptin and
vasopressin in a population from the community and in people with chronic kidney disease. J
Clin Endocrinol Metab 99:4656-4663 (IF :5.5)
145. Saulnier, P. J., E. Gand, S. Ragot, G. Ducrocq, J. M. Halimi, C. Hulin-Delmotte, P. Llaty, D.
Montaigne, V. Rigalleau, R. Roussel, G. Velho, P. Sosner, P. Zaoui, S. Hadjadj and S. S. Group
(2014). "Association of serum concentration of TNFR1 with all-cause mortality in patients with
type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE Cohort." Diabetes
Care 37(5): 1425-1431.
146. Schaepelynck P, Riveline JP, Renard E, Hanaire H, Guerci B, Baillot-Rudoni S, Sola-
Gazagnes A, Catargi B, Fontaine P, Millot L, Martin JF, Tachouaft H, Jeandidier N; EVADIAC
Group. Assessment of a new insulin preparation for implanted pumps used in the treatment of
type 1 diabetes. Diabetes Technol Ther. 16(9):582-9. doi: 10.1089/dia.2013.0369.
147. Sobngwi, E., A. P. Kengne, J. B. Echouffo-Tcheugui, S. Choukem, J. Sobngwi-Tambekou, E.
V. Balti, M. S. Pearce, V. Siaha, A. S. Mamdjokam, V. Effoe, E. Lontchi-Yimagou, O. T. Donfack, B.
Atogho-Tiedeu, P. Boudou, J. F. Gautier and J. C. Mbanya (2014). "Fasting insulin sensitivity
indices are not better than routine clinical variables at predicting insulin sensitivity among Black
Africans: a clamp study in sub-Saharan Africans." BMC Endocr Disord 14: 65.
148. Toubal, A., E. Treuter and N. Venteclef (2014). An > relationship between
GPS2 and the adipose tissue in human obesity. Med Sci (Paris) 30(1): 15-18.
149. ■ Venteclef, N. and P. Ferre (2014). Liver X receptor: from metabolism to cancer.
Biochem J 459(2): e1-3.
150. Voisin V, Decleves AE, Hubert V, Colombaro V, Giordano L, Habsch I, Bouby N, Nonclercq
D and Caron N (2014). Protection of Wistar Furth rats from post-ischemic acute renal injury : a
role for Nitric oxide and Thromboxane ? Clin Exp Pharmacol Physiol 41 (11): 911-920
151. Wood, A. R… R. Roussel… M. E. Goddard, P. M. Visscher, J. N. Hirschhorn and T. M.
Frayling (2014). "Defining the role of common variation in the genomic and biological
architecture of adult human height." Nat Genet 46(11): 1173-1186.
2013
152. ✏ Alzaid, F., H. M. Cheung, V. R. Preedy and P. A. Sharp (2013). Regulation of glucose
transporter expression in human intestinal Caco-2 cells following exposure to an anthocyanin-
rich berry extract. PLoS One 8(11): e78932.
153. Berrou, J., S. Fougeray, M. Venot, V. Chardiny, J. F. Gautier, N. Dulphy, A. Toubert and M.
N. Peraldi (2013). "Natural killer cell function, an important target for infection and tumor
protection, is impaired in type 2 diabetes." PLoS One 8(4): e62418.
154. Bonnefond, A., P. J. Saulnier, M. G. Stathopoulou, N. Grarup, N. C. Ndiaye, R. Roussel, M.
A. Nezhad, A. Dechaume, O. Lantieri, S. Hercberg, T. Lauritzen, B. Balkau, J. S. El-Sayed
Moustafa, T. Hansen, O. Pedersen, P. Froguel, G. Charpentier, M. Marre, S. Hadjadj and S.
Visvikis-Siest (2013). "What is the contribution of two genetic variants regulating VEGF levels to
type 2 diabetes risk and to microvascular complications?" PLoS One 8(2): e55921.
155. Bonnet, F., R. Roussel, A. Natali, S. Cauchi, J. Petrie, M. Laville, L. Yengo, P. Froguel, C.
Lange, O. Lantieri, M. Marre, B. Balkau, E. Ferrannini, Desir and R. S. Groups (2013). "Parental
history of type 2 diabetes, TCF7L2 variant and lower insulin secretion are associated with
incident hypertension. Data from the DESIR and RISC cohorts." Diabetologia 56(11): 2414-2423.
156. Bottolo L, Chadeau-Hyam M, Hastie DI, Zeller T, Liquet B, Newcombe P, Yengo L, Wild
PS, Schillert A, Ziegler A, Nielsen SF, Butterworth A, Ho WK, Castagné R, Munzel T, Tregouet D,
Falchi M, Cambien F, Nordestgaard BG, Fumeron F, Tybjærg-Hansen A, Froguel P, Danesh J,
Petretto E, Blankenberg S, Tiret L, Richardson S (2013). GUESS-ing polygenic associations with
multiple phenotypes using a GPU-based Evolutionary Stochastic Search algorithm. PLOS
Genetics 9(8): e1003657
12
Group D: evaluation campaign 2017 - 2018
Department for the evaluation of research unitsResearch unit evaluation
November 2016
157. Brioude, F., J. Bouligand, B. Francou, J. Fagart, R. Roussel, S. Viengchareun, L. Combettes,
S. Brailly-Tabard, M. Lombes, J. Young and A. Guiochon-Mantel (2013). "Two families with
normosmic congenital hypogonadotropic hypogonadism and biallelic mutations in KISS1R (KISS1
receptor): clinical evaluation and molecular characterization of a novel mutation." PLoS One
8(1): e53896.
158. Choukem, S. P., E. Sobngwi, P. Boudou, L. S. Fetita, R. Porcher, F. Ibrahim, B. Blondeau,
P. Vexiau, F. Mauvais-Jarvis, F. Calvo and J. F. Gautier (2013). "beta- and alpha-cell dysfunctions
in africans with ketosis-prone atypical diabetes during near-normoglycemic remission." Diabetes
Care 36(1): 118-123. (IF: 8.9)
159. Duclos, M., J. M. Oppert, B. Verges, V. Coliche, J. F. Gautier, Y. Guezennec, G. Reach, G.
Strauch, S. F. D. diabetes and g. physical activity working (2013). "Physical activity and type 2
diabetes. Recommandations of the SFD (Francophone Diabetes Society) diabetes and physical
activity working group." Diabetes Metab 39(3): 205-216.
160. Enhörning S, Bankir L, Bouby N, Struck J, Hedblad BO, Persson M, Morgenthaler NG,
Nilsson PM, Melander O (2013). Copeptin, a marker of vasopressin, in abdominal obesity,
diabetes and microalbuminuria: The prospective Malmö Diet and Cancer Study-Cardiovascular
Cohort. Int J Obesity Int J Obes (Lond). Apr;37(4):598-603
161. Ferrarezi DAF, Bellili-Muñoz N, Dubois-Laforgue D, Cheurfaa N, Lamri A, Reis AF, Le
Feuvre C, Roussel R, Fumeron F, Timsit J, Marre M, Velho G (2013). Allelic variations in the
vitamin D receptor (VDR) gene are associated with increased risk of coronary artery disease in
type 2 diabetic subjects. The DIABHYCAR Prospective Study. Diab Metab 39:263–270
162. Lamri A, Poli A, Emery N, Bellili N, Velho G, Lantieri O, Balkau B, Marre M, Fumeron F
(2013). The lactase persistence genotype is associated with body mass index and dairy
consumption in the D.E.S.I.R. study. Metabolism 62:1323-1329
163. Messadi E, Aloui Z, Belaidi E, Vincent MP, Couturier-Lepetit E, Waeckel L, Decorps J,
Bouby N, Gasmi A, Karoui H, Ovize M, Alhenc-Gelas F, Richer C (2013). Cardioprotective effect of
VEGF and Venom VEGF-like protein ICPP in acute myocardial ischemia in mice. Effect on
mitochondrial function. J Cardiovasc Pharmacol 2013, (3):274-81
164. Mohammedi K, Patente TA, Bellili-Muñoz N, Driss F, Monteiro MB, Roussel R, Pavin EJ,
Fumeron F, Azevedo MJ, Canani LH, Hadjadj S, Marre M, Corrêa-Giannella ML, Velho G (2013).
Catalase activity, allelic variations in the catalase gene and risk of kidney complications in
subjects with type 1 diabetes. Diabetologia 56:2733-2742
165. Potier, L., L. Waeckel, C. Richer, R. Roussel, N. Bouby and F. Alhenc-Gelas (2013). "Tissue
kallikrein, blood pressure regulation, and hypertension: insight from genetic kallikrein
deficiency." Biol Chem 394(3): 329-333.
166. Potier, L., L. Waeckel, M. P. Vincent, C. Chollet, F. Gobeil, Jr., M. Marre, P. Bruneval, C.
Richer, R. Roussel, F. Alhenc-Gelas and N. Bouby (2013). "Selective kinin receptor agonists as
cardioprotective agents in myocardial ischemia and diabetes." J Pharmacol Exp Ther 346(1): 23-
30. (I.F.: 4.5)
167. Reutens, A. T., F. Bonnet, O. Lantieri, R. Roussel, B. Balkau and G. Epidemiological Study
on the Insulin Resistance Syndrome Study (2013). "The association between cystatin C and
incident type 2 diabetes is related to central adiposity." Nephrol Dial Transplant 28(7): 1820-
1829.
168. Roussel, R., S. Hadjadj, B. Pasquet, P. W. Wilson, S. C. Smith, Jr., S. Goto, F. Tubach, M.
Marre, A. Porath, M. Krempf, D. L. Bhatt and P. G. Steg (2013). "Thiazolidinedione use is not
associated with worse cardiovascular outcomes: a study in 28,332 high risk patients with
diabetes in routine clinical practice: brief title: thiazolidinedione use and mortality." Int J Cardiol
167(4): 1380-1384.
169. Sacre, K., M. Dehoux, M. P. Chauveheid, M. Chauchard, O. Lidove, R. Roussel and T. Papo
(2013). "Pituitary-adrenal function after prolonged glucocorticoid therapy for systemic
inflammatory disorders: an observational study." J Clin Endocrinol Metab 98(8): 3199-3205.
13
Group D: evaluation campaign 2017 - 2018
Department for the evaluation of research unitsResearch unit evaluation
November 2016
170. Samara A, Herbeth B, Ndiaye NC, Fumeron F, Billod S, Siest G, Visvikis-Siest S (2013).
Dairy product consumption, calcium intakes, and metabolic syndrome-related factors over 5
years in the STANISLAS study. Nutrition 29:519-524
171. Toubal, A., E. Treuter, K. Clement and N. Venteclef (2013). Genomic and epigenomic
regulation of adipose tissue inflammation in obesity. Trends Endocrinol Metab 24(12): 625-634.
172. Toubal, A., K. Clement, R. Fan, P. Ancel, V. Pelloux, C. Rouault, N. Veyrie, A. Hartemann,
E. Treuter and N. Venteclef (2013). SMRT-GPS2 corepressor pathway dysregulation coincides
with obesity-linked adipocyte inflammation. J Clin Invest 123(1): 362-379. (IF: 12.5)
173. ■ Valtat, B., J. P. Riveline, P. Zhang, A. Singh-Estivalet, M. Armanet, N. Venteclef, A.
Besseiche, D. P. Kelly, F. Tronche, P. Ferre, J. F. Gautier, B. Breant and B. Blondeau (2013). Fetal
PGC-1alpha overexpression programs adult pancreatic beta-cell dysfunction. Diabetes 62(4):
1206-1216.
174. Velho G, Bouby N, Hadjadj S, Matallah N, Mohammedi K, Fumeron F, Potier L, Bellili-
Munoz N, Taveau C, Alhenc-Gelas F, Bankir L, Marre M, Roussel R (2013). Plasma copeptin and
renal outcomes in patients with type 2 diabetes and albuminuria. Diabetes Care 36:3639-3645
(IF : 8.9)
175. Waeckel, L., L. Potier, C. Richer, R. Roussel, N. Bouby and F. Alhenc-Gelas (2013).
"Pathophysiology of genetic deficiency in tissue kallikrein activity in mouse and man." Thromb
Haemost 110(3): 476-483.
176. Wemeau, J. L. and J. F. Gautier (2013). "[Management of type 2 diabetes: new drugs,
new recommendations]." Presse Med 42(5): 828-829.
2012
177. Abi Khalil, C., R. Roussel, K. Mohammedi, N. Danchin and M. Marre (2012).
"Cause-specific mortality in diabetes: recent changes in trend mortality." Eur J Prev
Cardiol 19(3): 374-381.
178. Archer, A., N. Venteclef, A. Mode, M. Pedrelli, C. Gabbi, K. Clement, P. Parini, J.
A. Gustafsson and M. Korach-Andre (2012). Fasting-induced FGF21 is repressed by
LXR activation via recruitment of an HDAC3 corepressor complex in mice. Mol
Endocrinol 26(12): 1980-1990.
179. Benhamou PY, Catargi B, Delenne B, Guerci B, Hanaire H, Jeandidier N, Leroy
R, Meyer L, Penfornis A, Radermecker RP, Renard E, Baillot-Rudoni S, Riveline JP,
Schaepelynck P, Sola-Gazagnes A, Sulmont V, Tubiana-Rufi N, Durain D, Mantovani I,
Sola-Gazagnes A, Riveline JP; Société Francophone du Diabète.; Société Française
d'Endocrinologie.; EVAluation dans le Diabète des Implants ACtifs Group (2012). Real-
time continuous glucose monitoring (CGM) integrated into the treatment of type 1
diabetes: consensus of experts from SFD, EVADIAC and SFE. Diabetes Metab. Suppl
4:S67-83. doi: 10.1016/S1262-3636(12)71538-0.
180. Bonnefond, A., N. Clement, K. Fawcett, L. Yengo, E. Vaillant, J. L. Guillaume, A.
Dechaume, F. Payne, R. Roussel, S. Czernichow, S. Hercberg, S. Hadjadj, B. Balkau,
M. Marre, O. Lantieri, C. Langenberg, N. Bouatia-Naji, G. Meta-Analysis of, C. Insulin-
Related Traits, G. Charpentier, M. Vaxillaire, G. Rocheleau, N. J. Wareham, R. Sladek,
M. I. McCarthy, C. Dina, I. Barroso, R. Jockers and P. Froguel (2012). "Rare MTNR1B
variants impairing melatonin receptor 1B function contribute to type 2 diabetes." Nat
Genet 44(3): 297-301.
181. Decleves AE, Caron N, Voisin V, Legrand A, Bouby N, Kultti A, Tammi M,
Flamion B (2012). Synthesis and fragmentation of hyaluronan in renal ischemia. Nephrol
Dial Transpl (10):3771-81
182. Fumeron F, Vari IS, Grandchamp B, Balkau B (2012). Comment on: Park et al.
Association of Serum Ferritin and the Development of Metabolic Syndrome in Middle-
Aged Korean Men: A 5-Year Follow-up Study. Diabetes Care 35:2521-2526. Diabetes
Care 35:e92 (IF: 8.9)
183. Goossens, G. H., C. C. Moors, N. J. van der Zijl, N. Venteclef, R. Alili, J. W.
14
Group D: evaluation campaign 2017 - 2018
Department for the evaluation of research unitsYou can also read
